Marlborough-Based Hologic Acquires Biotheranostics for $230 Million
The following is a press release submitted to SOURCE through its business wire service. *** MARLBOROUGH – Hologic, Inc. has
Read moreThe following is a press release submitted to SOURCE through its business wire service. *** MARLBOROUGH – Hologic, Inc. has
Read more*** The following is a press release submitted to SOURCE media through its business wire service. *** MARLBOROUGH – Marlborough-based
Read moreMARLBOROUGH – Hologic, Inc. announced today, October 6, its Aptima® SARS-CoV-2 assay, which initially received Emergency Use Authorization (EUA) from
Read moreThe press release was submitted to SOURCE media through its business wire. *** MARLBOROUGH – Hologic, Inc., a medical technology
Read moreThe following is a press release *** MARLBOROUGH – A molecular assay for detecting the novel coronavirus SARS-CoV-2 (previously 2019-nCoV)
Read more